Global Adrenocortical Hormones API Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Adrenocortical Hormones API Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Cortical Hormone, fully called "Adrenal Cortical Hormone", are a group of steroids secreted by adrenal corticosteroids, mainly including glucocorticoids and salt corticosteroids, as well as a small amount of sex hormones, which are important hormones involved in the metabolism of sugar, fat and protein.
Adrenocortical Hormones API report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Adrenocortical Hormones API market is projected to reach US$ 3269.9 million in 2034, increasing from US$ 2107.3 million in 2022, with the CAGR of 6.4% during the period of 2024 to 2034. Demand from Injectable Drugs and Oral Drugs are the major drivers for the industry.
Leading products represented by Pfizer CentreOne, Sanofi, GlaxoSmithKline, Tianjin Pharmaceutical Group and Xianju Pharma have occupied a leading position in the international market, and the market share of them is over 40% in the global market. The North American market is the most important consumer region, accounting for about 40% of the global total in 2019.Europe is second only to North America, accounting for less than 30% of the global market. The downstream markets for the use of corticosteroid apis are mainly injectable, oral, topical, and inhaled. Among them, oral drugs accounted for the largest proportion, accounting for nearly 50% of the market in 2019.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Adrenocortical Hormones API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Pfizer CentreOne
Sanofi
GlaxoSmithKline
Tianjin Pharmaceutical Group Co., Ltd.
Xianju Pharma
Guangdong VTR Bio-Tech Co., Ltd
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Hovione
Shandong Xinhua Pharmaceutical Company Limited
Steroid SpA
Junye Pharmaceutical Co., Ltd.
Avik Pharmaceutical
Great Pacific Exports
Shanghai New Hualian Pharmaceutical Co., Ltd
Shandong Taihua Bio & Tech Stock Co., Ltd
Tianjin Pacific Pharmaceutical Co., Ltd (TJPP)
Teva
Zhejiang Xianju Xianle Pharmaceutical Co., Ltd.
Jiangsu Lianhuan Pharmaceutical Co., Ltd
Shandong Sito Bio-technology CO., LTD
Segment by Type
Prednisone Series
Dexamethasone Series
Betamethasone Series
Hydrocortisone Series
Others
Injectable Drugs
Oral Drugs
For External Use Drugs
Inhalation Drugs
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Adrenocortical Hormones API market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Adrenocortical Hormones API, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Adrenocortical Hormones API industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Adrenocortical Hormones API in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Adrenocortical Hormones API introduction, etc. Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Adrenocortical Hormones API market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Adrenocortical Hormones API report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Adrenocortical Hormones API market is projected to reach US$ 3269.9 million in 2034, increasing from US$ 2107.3 million in 2022, with the CAGR of 6.4% during the period of 2024 to 2034. Demand from Injectable Drugs and Oral Drugs are the major drivers for the industry.
Leading products represented by Pfizer CentreOne, Sanofi, GlaxoSmithKline, Tianjin Pharmaceutical Group and Xianju Pharma have occupied a leading position in the international market, and the market share of them is over 40% in the global market. The North American market is the most important consumer region, accounting for about 40% of the global total in 2019.Europe is second only to North America, accounting for less than 30% of the global market. The downstream markets for the use of corticosteroid apis are mainly injectable, oral, topical, and inhaled. Among them, oral drugs accounted for the largest proportion, accounting for nearly 50% of the market in 2019.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Adrenocortical Hormones API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Pfizer CentreOne
Sanofi
GlaxoSmithKline
Tianjin Pharmaceutical Group Co., Ltd.
Xianju Pharma
Guangdong VTR Bio-Tech Co., Ltd
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Hovione
Shandong Xinhua Pharmaceutical Company Limited
Steroid SpA
Junye Pharmaceutical Co., Ltd.
Avik Pharmaceutical
Great Pacific Exports
Shanghai New Hualian Pharmaceutical Co., Ltd
Shandong Taihua Bio & Tech Stock Co., Ltd
Tianjin Pacific Pharmaceutical Co., Ltd (TJPP)
Teva
Zhejiang Xianju Xianle Pharmaceutical Co., Ltd.
Jiangsu Lianhuan Pharmaceutical Co., Ltd
Shandong Sito Bio-technology CO., LTD
Segment by Type
Prednisone Series
Dexamethasone Series
Betamethasone Series
Hydrocortisone Series
Others
Segment by Application
Injectable Drugs
Oral Drugs
For External Use Drugs
Inhalation Drugs
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Adrenocortical Hormones API market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Adrenocortical Hormones API, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Adrenocortical Hormones API industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Adrenocortical Hormones API in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Adrenocortical Hormones API introduction, etc. Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Adrenocortical Hormones API market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices